Dr. Ostergard is the sort of doctor that others claim they trained with as part of the bragging rights. Here is his contact information at the University of Louisville School of Medicine. Dr. Ostergard is also the past president of the American Urogynecologic Society.
Dr. Ostergard writes that many of the properties of surgical mesh were not taken into account before the marketing of mesh kits. This information was available to the Food and Drug Administration and the mesh kit manufacturers. He writes that the first polypropylene mesh kit cleared by the FDA was used in the transvaginal tape or TVT procedure to treat stress urinary incontinence.
The kit clearance was granted in 1998. Two years earlier in 1996, a woven polyester mesh kit obtained FDA approval.
Dr. Ostergard provides citations for what was known about kits implanted in women until 2003 at which time many new kits were cleared.
The information had been accumulating since the 1950s he says, and provides the documentation that was available for years and includes some of the following and more:
The article which is available here. in the International International Urogynecology Journal, Volume 22, Number 7, Published April 2011, Open Access at Springerlink.com
Polypropylene is the polymer material that make up the majority of hernia and pelvic meshes even though there are known problems with the material.
Why is the leading urogynecology organization saying that SUI mesh is not a problem where there have been thousands of defective product lawsuits?
In this Mesh News Desk podcast, Dr. Donald Ostergard talks about how to find a doctor to do pure tissue repair rather than use polypropylene mesh, tests, and treatments for SUI.